DABRAFENIB vs DACTINOMYCIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DABRAFENIB vs DACTINOMYCIN: Safety Overview
| Metric | DABRAFENIB | DACTINOMYCIN |
|---|---|---|
| Total FAERS Reports | 19,305 | 2,858 |
| Deaths Reported | 4,165 | 507 |
| Death Rate | 21.6% | 17.7% |
| Hospitalizations | 5,325 | 721 |
| Average Patient Age | 58.3 yrs | 18.8 yrs |
| % Female Patients | 48.0% | 65.9% |
| FDA Approval Date | Mar 16, 2023 | Approved Prior to Jan 1, 1982 |
| Manufacturer | Novartis Pharmaceuticals Corporation | Eugia US LLC |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | Discontinued |